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General Approaches for Combining Multiple Rare Variant Associate Tests
Provide Improved Power Across a Wider Range of Genetic Architecture
Abstract
In the wake of the widespread availability of genome sequencing data made possible by way of nextgeneration
technologies, a flood of gene‐based rare variant tests have been proposed. Most methods claim superior power
against particular genetic architectures. However, an important practical issue remains for the applied
researcher—namely, which test should be used for a particular association study which may consider multiple
genes and/or multiple phenotypes. Recently, tests have been proposed which combine individual tests to
minimize power loss while improving the robustness to a wide range of genetic architectures. In our analysis,
we propose an expansion of these approaches, by providing a general method that works for combining an
arbitrarily large number of any gene‐based rare variant test—a flexibility typically not available in other
combined testing methods. We provide a theoretical framework for evaluating our combined test to provide
direct insights into the relationship between test‐test correlation, test power and the combined test power
relative to individual testing approaches and other combined testing approaches. We demonstrate that our
flexible combined testing method can provide improved power and robustness against a wide range of genetic
architectures. We further demonstrate the performance of our combined test on simulated genotypes, as well
as on a dataset of real genotypes with simulated phenotypes. We support the increased use of flexible
combined tests in practice to maximize robustness of rare‐variant testing strategies against a wide‐range of
genetic architectures.
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 Over the past five years, numerous gene-based rare 
variant tests of association have been proposed, each of 
which attempt to combine variants within a gene or 
region of interest into a single association statistic, with a 
goal of providing more power than a strategy which 
analyzes each variant separately. Simulation results have 
shown that many of these individual tests provide good 
power for particular genetic architectures, but not others. 
We have developed a general strategy for combining any 
two or more gene-based rare variant tests using an 
adaptive approach, which yields a single p-value 
representing the cumulative evidence for association 
across the set of gene-based tests. For example this 
strategy can take any threshold based test and turn it into 
a variable-threshold test, combine similar tests (similar 
statistic with alternative weighting strategies), or combine 
substantially different tests (e.g., burden tests and 
variance components tests). Using simulation we provide 
guidance on the tradeoff between power gains and test 
robustness versus the number of tests being combined, a 
result which is based on the correlation structure of the 
tests are under the null hypothesis of no association. 
Finally, we demonstrate how recent results from our 
group which suggested a substantially different gene-
based test which is robust to high proportions of non-
causal variants, combined with other popular tests 
(burden and variance component tests), can provide 
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I. Abstract IV. Results 
References 
II. Introduction 
• Over the years, many tests of genotype-phenotype 
association have been proposed , and recent work 
has shown that different types of these tests are 
more or less powerful  under different genetic 
architectures. 
• Recent work by our group has classified these tests 
into two groups: Length tests (also known as burden, 
collapsing, and/or linear tests) and Joint tests 
(alternatively, variance components or quadratic 
tests).  (Liu et al., 2013) 
• Length tests can be powerful when the proportion of 
causal variants in the region is large and the effects 
of the causal variants tend to be similar. Joint tests 
can be more powerful than length tests when there 
are larger proportions of non-causal variants and 
there is more variation in the effects of causal 
variants (e.g., both risk increasing and risk-reducing 
variants). 
• Four recent papers have proposed combining test 
statistics across both the length and joint classes to 
yield more powerful test statistics (Derkach et al., 
2013; Lee, Wu, et al., 2012; Lee, Emond, et al., 
2012; Liu et al., 2013).  
• Liu et al. (2013) also showed that length and joint 
tests can be further classified by the norm, p, used in 
the formulation of the test statistic. To date, most 
length tests use p=1 and most joint tests use p=2. 
Liu et al. demonstrate that higher choices of 
norm  provide increased robustness to large 
proportions of non-causal variants. 
• More general test-combining strategies (such as 
combinations that include length and joint tests with 
higher norms) may yield more powerful results when 
the component tests being combined are powerful 
for a wide range of genetic architectures. 
 
Table 1 – List of combined Tests Used 
Simulation Study # 1: Investigating the behavior of Min(p) and 
Fisher’s 
Simulation Study # 2: Investigating the behavior of combinations of 
gene-based rare variant tests across different genetic disease 
models 
• 197 simulation settings, representing all possible combinations of 
the following parameters:  
 (1)   Number of single nucleotide variants (SNVs)   (32 or 64) 
 (2)   Proportion of non-causal SNVs (0, ¼, ½, ¾, 7/8, 15/16,  
  31/32, 63/64, 1) 
 (3)   Proportion of causal SNVs that increase     
  disease risk (0, ¼, ½, ¾, 1), with the remaining causal  
  SNVs causing a decline in disease risk 
 (4)   Relative risk of causal, risk increasing SNVs (1.1, 1.5 and  
  2.0); fixed the relative risk of risk-reducing SNVs at 0.5 
 (5) Minor allele frequencies simulated in 3:1 ratio of less   
  common (0.1% population MAF) to more common (1%  
  MAF), spread evenly across all non-causal and causal  
  SNVs. 
• 500 samples generated at each simulation setting, 
• Each individual and combined test applied to each sample (with 
separate p-values for Min(p), Fisher’s, and Bonferonni for each 
combined test). 
• Empirical power estimates computed as percentage of p-values 






Description of the permutation strategy 
• Derkach et al. (2012) propose an efficient 
permutation strategy for assessing the significance 
of S which we extend and apply here 
• Utilize any number of rare variant tests. 
• Find the minimum p-value of the tests.. 
• Through permutation, empirically find the distribution 
of minimum p- values. 
• Adjust the actual minimum p-value according to the 
empirical distribution. 
Rare variant tests 
• List of  individual tests considered: Sequence Kernel 
Adaptive Test (SKAT); Sequence Kernel Adaptive 
Test-Optimal (SKAT-O); Combined Multivariate and 
Collapsing Test (CMC); Length tests with different 
norms (L(p)); Joint tests with different norms (J(p)); 
Odds Ratio Weighted Sum Statistic (ORWSS)  
• List of the combinations explored: 
 
Table 1.  Left column gives name of combined test, right column lists the individual tests that 
make up the combined test 
Table 2. Lists percent of 197 simulations where a particular combined or individual test had 
the highest power, or was within 5% of the most powerful test for that simulation setting.  
The tests were ranked by how often they were within 5% of the most powerful test. 
III. Methods 
Length tests with different 
norms  
L(1), L(2), L(4), L(∞) 
Joint tests with different 
norms  
J(1), J(2), J(4), J(∞) 





Similar length tests  CMC, L(1) 
Similar joint tests SKAT, J(2) 
Typical length-joint combined 
test  
SKAT, CMC 
Length and joint tests across 
norms  
L(1), L(2), L(4), L(∞),(J(1), 
J(2), J(4), J(∞)) 
Length and joint with some 
norms  
L(1), L(4), J(1), J(4) 
Generic length-joint combined 
test  
L(1), J(2) 







L(1), L(2), L(4), L(∞),J(1), 
J(2), J(4), J(∞) 
Heterogeneous combined test 
#2 
SKAT-O, J(∞) 






ORWSS(≠0), L(1), L(2), L(4), 
L(∞),J(1), J(2), J(4), J(∞) 
A) Simulations 
Min(p) vs Bonferroni vs Fishers 
• Across the 197 simulation settings and 12 combined 
tests (2364 possibilities), there were only 10 times where 
power of the Bonferroni approach exceeded the power of 
the Min(p) approach and power gains were minimal 
(ranging from 0.002 to 0.004) in these cases. 
• Across 197 simulation settings, 36.5% of time Min(p) is 
more powerful than Fishers  
• Minimum p-value increases power when tests are very 
different, but powerful in certain situations (if only 1 test 
has a p-value of .001, but the others have p-values that 
are very high, min-p works well) 
• Fisher’s increases power when tests of different classes 
all return low p-values (because it combines the 
information). 
Correlation structure between tests 
• The performance of Min(p) and Fishers methods will be 
affected by the correlation structure between the tests 






Table 2 – Most Powerful Tests  Figure 1 – Heat Map of Combined Tests 
Figure 1. To understand how the p-values between different tests are 
correlated with each other we created a Heat Map of the p-values 
between different tests across all simulation settings 
 
Figure 2 – When Fishers generic combo(L1,J2) is more  
  powerful than L1(82.2% of sims) and   
  J2(37.5% of sims) 
Figure 3 – Hetero2 vs (L1,J2) Power on 80-98.4% Non  
  Causal Simulation Settings 
Figure 3. Hetero2 has greater power than (L1,J2) 79.2% of sims 
